4
Total investments
4
Early stage
0
Mid stage
0
Late stage
14y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2023
We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
Investor & Member of the Advisory Board
Jun 2020
Elucidate is a financial crime risk management company enabling financial institutions to benchmark and price financial crime risk through the Elucidate FinCrime Index (EFI), an automated platform developed in partnership with leading global correspondent banks.
Elucidate is an approved benchmark administrator, authorised by the Federal Financial Supervisory Authority (BaFin) and registered with the European Security and Markets Authority (ESMA).
Investor
Nov 2015
has·to·be paves the way for sustainable mobility. With its comprehensive operating system and innovative services, has·to·be provides everything companies require to enjoy success in the field of eMobility: from the carefree operation of eCharging stations to the end-to-end management of worldwide mobility solutions.
More than 100 employees from ten nations work at the headquarters of has·to·be gmbh in the federal province of Salzburg and in its offices in Munich and Vienna. Since 2019, the Volkswagen Group has been a strong strategic partner of has·to·be.
Investor
Oct 2012
DocDoc is the world’s first patient intelligence company. Our vision is to empower patients to make data-driven healthcare decisions which are safe, transparent, and fair.
We use technology in conjunction with medically trained professionals to optimise healthcare outcomes and cost, and enhance the patient’s end-to-end healthcare journey. DocDoc combines AI-powered doctor discovery, telemedicine, and digital Third Party Administrator services onto a single platform. With this platform, DocDoc enables insurance companies to offer a differentiated product in a crowded market, employers to attract and retain world-class employees, and governments to improve accessibility and affordability of healthcare services for their citizens.
DocDoc is an independent company with deep expertise in healthcare quality. We seek physicians, clinics, and hospitals with excellent outcomes who believe they are the best at what they do. We then spend hours with each doctor, investigating quality of care and documenting procedures and conditions where the physician excels. We review national records to confirm credentials and discover any legal action. Then, we enter information from multiple sources into a sophisticated system that finds a best match between a unique patient need and unique physician experience.
Our model is that everyone wins. The patient finds a highly qualified doctor to treat their condition. The physician, who excels in specific treatments and procedures, has a company validate their expertise and send select patients to them so they can focus on clinical care. The insurance firms, knowing that happy policyholders maintain memberships and employers knowing that healthy employees are more productive, pay us a modest fee to assure their patients make informed medical decisions. The service is free of charge to providers to ensure transparency and avoid conflict of interest.
Experience · 8 entries
All (8)
Investments (4)
Founder (2)
2026
2024
General Partner
Sep 2024
Seed X Liechtenstein AG is a Venture Capital Firm based in Liechtenstein. We invest in pre-Seed, Seed and Series A ventures in Europe with a focus on Fintech, Insurtech, Proptech and Legaltech.
2023
Investor
Dec 2023
We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
2020
Investor & Member of the Advisory Board
Jun 2020
Elucidate is a financial crime risk management company enabling financial institutions to benchmark and price financial crime risk through the Elucidate FinCrime Index (EFI), an automated platform developed in partnership with leading global correspondent banks.
Elucidate is an approved benchmark administrator, authorised by the Federal Financial Supervisory Authority (BaFin) and registered with the European Security and Markets Authority (ESMA).
2016
Founder & General Partner
May 2016
APEX Ventures is a European venture capital firm focusing on deep tech companies. The team act not only as investors but also as company builders with a mission to support the most talented startup teams in building global market leaders.
Show all 8 entries ↓
Investment activity
2012–2023 · 4 investments
Recent (last 2 years)Earlier
